In the current study, on the basis of identifying the possible association between the downregulation of IL-22 and the progression of DN, we provided in vivo evidence for the first time that IL-22 significantly alleviated renal injury and fibrosis in established DN. This evidence concerns the gene IL22 and liver dysplastic nodule.